NCT02487823View on ClinicalTrials.gov

Dose Finding Study of BKM 120 in Combination With LH-RH Agonists and Bicalutamide in Men With Non Castrate Metastatic Prostate Cancer

PHASE1TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions
Non Castrate Metastatic Prostate Cancer
Interventions
DRUG

BKM120 in combination with LH-RH agonists (suprefact) and bicalutamide

BKM 120, LH-RH agonists and Bicalutamide

Trial Locations (1)

13009

Institut Paoli Calmettes, Marseille

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Institut Paoli-Calmettes

OTHER